Carlo Pozzilli
University Avenue 30
Rome, Italy
Rome, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 229 publications
Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: July 13, 2026
Profiling the long-term risk of severe adverse events in a cohort of multiple sclerosis patients treated with different treatment sequences: Results from the Italian Multiple Sclerosis and Related Disorders Registry (I-MS&RD) (ProSA study).
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: July 04, 2026
Use of High-Efficacy Therapy in Children With Multiple Sclerosis to Prevent Long-Term Disability.
Journal: Neurology
Published: May 29, 2026
Clinical, structural, and functional MRI features predicting PIRMA at 5-year follow-up in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: May 23, 2026
Targeting shared immune pathways in multiple sclerosis and type 1 diabetes: Therapeutic insights from monoclonal antibodies.
Journal: Autoimmunity reviews
Published: March 26, 2026
A proof-of-concept study on the relationship between lifetime Estrogen exposure, menopausal transition, and neurodegeneration in women with multiple sclerosis.
Journal: Journal of the neurological sciences
Published: January 14, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS.
Journal: Journal of neurology
Published: December 05, 2025
Predictors of short-term, relapse-independent progression in multiple sclerosis: A machine learning approach based on clinical data and conventional MRI-derived features.
Journal: Journal of the neurological sciences
Published: December 03, 2025
Addressing autoimmune comorbidities in multiple sclerosis: A case report of ulcerative colitis remission in a patient treated with cladribine tablets.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: December 01, 2025
Disability Worsening Phenotypes in Multiple Sclerosis and Impact of Disease-Modifying Treatments.
Journal: Neurology
Published: November 24, 2025
Long-term safety and efficacy of ponesimod in participants with relapsing multiple sclerosis: results from the phase 3 OPTIMUM 5-year long term extension study.
Journal: Journal of neurology
Published: November 03, 2025
How premorbid structural reserve affects disability accrual in multiple sclerosis.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: October 08, 2025
Last Updated: 09/26/2026